Position in CYTK
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,874
+$820 QoQ
Shares Held
22
+37.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#441
of 477 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bogart Wealth, LLC holds $13,935,070 across 51 Biotechnology names. CYTK ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,703 | $13,760,911 | |
| 2 | MRNA |
Moderna, Inc.
|
437 | $30,603 | |
| 3 | EXEL |
Exelixis, Inc.
|
494 | $26,878 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
46 | $13,847 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22 | $13,717 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
63 | $11,798 | |
| 7 | RPRX |
Royalty Pharma plc
|
186 | $10,429 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
123 | $9,752 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,874 | 22 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,054 | 16 | Shares | Sole | 2026-04-28 | |
| 2025-06-30 | $396 | 12 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||